Related Experiment Videos
[Leukemia in delta-GAG-MYC transgenic mice]
Voprosy Onkologii
|January 1, 1994
Summary
Transgenic mice with the delta-gag-myc gene developed hemopoietic diseases, including lymphoma and myeloma. These mice serve as a model for studying leukemia development and progression.
Area of Science:
- Genetics and Molecular Biology
- Hematology
- Oncology
Context:
- Transgenic mouse models are crucial for understanding complex diseases.
- The delta-gag-myc genetic construction is investigated for its role in disease development.
Purpose:
- To investigate the long-term effects of the delta-gag-myc gene in a transgenic mouse model.
- To characterize the spectrum of hemopoietic diseases induced by this genetic modification.
Summary:
- Transgenic mice carrying the delta-gag-myc gene were observed throughout their lifespan.
- Nineteen out of 119 mice developed hemopoietic diseases: lymphoid tissue hyperplasia, lymphoma, lymphosarcoma, and myeloma.
- Lymphosarcoma and myeloma were fatal, appearing between 18-29 months and 3-9 months, respectively.
Impact:
- This study establishes transgenic mice with delta-gag-myc as a valuable model for leukemia research.
- Findings contribute to understanding the pathogenesis of specific hematologic malignancies.
- The model allows for detailed investigation into the patterns of leukemia development.